CollPlant Biotechnologies (CLGN) Long-Term Investments (2022 - 2025)

CollPlant Biotechnologies' Long-Term Investments history spans 4 years, with the latest figure at $76000.0 for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 35.59% year-over-year to $76000.0; the TTM value through Dec 2025 reached $76000.0, down 35.59%, while the annual FY2025 figure was $76000.0, 35.59% down from the prior year.
  • Long-Term Investments reached $76000.0 in Q4 2025 per CLGN's latest filing, down from $118000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $188000.0 in Q4 2022 to a low of $57000.0 in Q4 2023.
  • Average Long-Term Investments over 4 years is $109750.0, with a median of $97000.0 recorded in 2024.
  • Peak YoY movement for Long-Term Investments: tumbled 69.68% in 2023, then skyrocketed 107.02% in 2024.
  • A 4-year view of Long-Term Investments shows it stood at $188000.0 in 2022, then crashed by 69.68% to $57000.0 in 2023, then skyrocketed by 107.02% to $118000.0 in 2024, then crashed by 35.59% to $76000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLGN's Long-Term Investments are $76000.0 (Q4 2025), $118000.0 (Q4 2024), and $57000.0 (Q4 2023).